Overview
The ICD-10 code D751 is used to classify hereditary factor XI deficiency, a rare bleeding disorder that affects the blood’s ability to clot properly. Factor XI, also known as plasma thromboplastin antecedent, is a protein essential for the clotting cascade. This deficiency can lead to prolonged bleeding after injury or surgery, as well as an increased risk of spontaneous bleeding episodes. D751 is characterized by reduced levels of factor XI in the blood, which can be inherited in an autosomal recessive pattern.
Signs and Symptoms
Individuals with hereditary factor XI deficiency may experience prolonged bleeding after minor injuries, surgery, or dental procedures. They may also have frequent nosebleeds, bruising easily, and heavy menstrual bleeding in females. In severe cases, uncontrolled bleeding can occur in the joints, muscles, or internal organs. Some individuals may not exhibit any symptoms until they experience a significant bleeding event.
Causes
Hereditary factor XI deficiency is caused by mutations in the F11 gene, which provides instructions for making factor XI. These mutations result in reduced levels or abnormal function of factor XI in the blood. The condition is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene (one from each parent) to develop the disorder. Carriers of a single copy of the mutated gene usually do not show any symptoms.
Prevalence and Risk
Factor XI deficiency is a rare disorder, with an estimated prevalence of 1 in 1,000 to 1 in 1,000,000 individuals worldwide. The condition is more common in individuals of Ashkenazi Jewish descent, with a prevalence of 1 in 30 in this population. Factors that increase the risk of bleeding in individuals with factor XI deficiency include trauma, surgery, dental procedures, and childbirth. It is important for individuals with the condition to inform their healthcare providers to ensure appropriate management of bleeding episodes.
Diagnosis
Diagnosing hereditary factor XI deficiency involves a series of blood tests to measure the levels and function of factor XI. Genetic testing can also be used to identify mutations in the F11 gene. Other coagulation tests, such as activated partial thromboplastin time (aPTT) and prothrombin time (PT), may be performed to evaluate the overall clotting function. A thorough medical history, including family history of bleeding disorders, is essential for an accurate diagnosis.
Treatment and Recovery
The treatment of hereditary factor XI deficiency focuses on preventing and managing bleeding episodes. For individuals with mild deficiency, treatment may not be necessary. In cases of significant bleeding, options may include desmopressin (DDAVP), cryoprecipitate, fresh frozen plasma, or recombinant factor XI concentrates. Antifibrinolytic medications can also be used to reduce bleeding during minor procedures or dental work. Regular monitoring and coordination with a hematologist are important for optimal management and recovery.
Prevention
There is currently no known method for preventing hereditary factor XI deficiency, as it is an inherited genetic condition. However, individuals with a family history of the disorder can undergo genetic counseling to understand their risk of passing it on to their children. It is important to inform healthcare providers about the condition to ensure appropriate management during medical procedures and childbirth.
Related Diseases
Hereditary factor XI deficiency is related to other bleeding disorders, such as hemophilia A and B, von Willebrand disease, and rare factor deficiencies. These conditions also affect the clotting factors in the blood and can result in prolonged bleeding episodes. Individuals with a family history of bleeding disorders may be at risk for multiple conditions and should undergo comprehensive testing and evaluation by a hematologist.
Coding Guidance
When assigning the ICD-10 code D751 for hereditary factor XI deficiency, it is important to document the type and severity of the deficiency, as well as any associated symptoms or complications. It is also crucial to specify whether the deficiency is congenital or acquired and to include any genetic testing results or family history of bleeding disorders. Accurate coding and documentation help ensure appropriate management and continuity of care for individuals with factor XI deficiency.
Common Denial Reasons
Denials for claims related to hereditary factor XI deficiency may occur due to insufficient documentation of the condition, lack of specificity in coding, or incomplete medical records. It is essential to clearly describe the patient’s symptoms, diagnostic evaluations, treatment plan, and follow-up care to support the medical necessity of services provided. Working closely with healthcare providers and coding professionals can help prevent denials and ensure timely reimbursement for necessary care.